DE60326465D1 - Herstellung von m(co)3-komplexen durch festphasentechniken durch metal-unterstützte trennung vom festen träger - Google Patents

Herstellung von m(co)3-komplexen durch festphasentechniken durch metal-unterstützte trennung vom festen träger

Info

Publication number
DE60326465D1
DE60326465D1 DE60326465T DE60326465T DE60326465D1 DE 60326465 D1 DE60326465 D1 DE 60326465D1 DE 60326465 T DE60326465 T DE 60326465T DE 60326465 T DE60326465 T DE 60326465T DE 60326465 D1 DE60326465 D1 DE 60326465D1
Authority
DE
Germany
Prior art keywords
sub
solid
sup
complexes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326465T
Other languages
English (en)
Inventor
Roger Alberto
Stefan Mundwiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Zuerich
Original Assignee
Universitaet Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Zuerich filed Critical Universitaet Zuerich
Application granted granted Critical
Publication of DE60326465D1 publication Critical patent/DE60326465D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/025Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11Compounds covalently bound to a solid support

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60326465T 2002-09-03 2003-09-02 Herstellung von m(co)3-komplexen durch festphasentechniken durch metal-unterstützte trennung vom festen träger Expired - Lifetime DE60326465D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078743 2002-09-03
PCT/US2003/027665 WO2004022105A2 (en) 2002-09-03 2003-09-02 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support

Publications (1)

Publication Number Publication Date
DE60326465D1 true DE60326465D1 (de) 2009-04-16

Family

ID=31970414

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326465T Expired - Lifetime DE60326465D1 (de) 2002-09-03 2003-09-02 Herstellung von m(co)3-komplexen durch festphasentechniken durch metal-unterstützte trennung vom festen träger

Country Status (13)

Country Link
US (1) US20060165594A1 (de)
EP (1) EP1536844B1 (de)
JP (1) JP2006514612A (de)
KR (1) KR20050086412A (de)
CN (1) CN100366297C (de)
AT (1) ATE424222T1 (de)
AU (1) AU2003268431B2 (de)
CA (1) CA2497548A1 (de)
DE (1) DE60326465D1 (de)
ES (1) ES2323364T3 (de)
NO (1) NO20051573L (de)
PL (1) PL375530A1 (de)
WO (1) WO2004022105A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004283026A1 (en) * 2003-10-20 2005-05-06 Universitat Zurich Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
DE602005016648D1 (de) * 2004-01-08 2009-10-29 Univ Zuerich Metallkomplexe mit vitamin b12 als ligand

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899472A (en) * 1973-11-21 1975-08-12 Toray Industries Chelating resin and process for preparing the same
US6022966A (en) * 1993-11-22 2000-02-08 Neorx Corporation Pretargeting methods and compounds
DE69434810T2 (de) * 1993-11-16 2007-08-02 Bracco International B.V. Immobilisiertes markierungsverfahren
EP0879606A1 (de) * 1997-04-25 1998-11-25 Paul Scherrer Institut Verfahren zur Herstellung von facial Metall Tricarbonyl Verbindungen und ihre Anwendung zur Markierung von Biosubstraten
DE19860289C2 (de) * 1998-12-21 2003-11-13 Schering Ag Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
CZ20014603A3 (cs) * 1999-06-29 2002-11-13 Mallinckrodt Inc. Pouľití aminopolykarboxylátových ligandů při značení biologicky aktivních substrátů Tc-99m-trikarbonylovými prekurzory
ES2320407T3 (es) * 1999-10-05 2009-05-22 Mallinckrodt Inc. Fuente de monoxido de carbono para la preparacion de complejos de metal de trasnsicion y carbonilo.
US6359119B1 (en) * 2000-05-24 2002-03-19 Mallinckrodt Inc. Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate

Also Published As

Publication number Publication date
NO20051573L (no) 2005-03-29
US20060165594A1 (en) 2006-07-27
CN100366297C (zh) 2008-02-06
CN1703249A (zh) 2005-11-30
AU2003268431B2 (en) 2008-12-04
CA2497548A1 (en) 2004-03-18
WO2004022105A3 (en) 2004-04-22
EP1536844B1 (de) 2009-03-04
JP2006514612A (ja) 2006-05-11
ATE424222T1 (de) 2009-03-15
KR20050086412A (ko) 2005-08-30
ES2323364T3 (es) 2009-07-14
EP1536844A2 (de) 2005-06-08
PL375530A1 (en) 2005-11-28
WO2004022105A2 (en) 2004-03-18
AU2003268431A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
Mohler et al. . alpha.-Amino acid chelative complexation by an arylboronic acid
TW200716518A (en) Acetylene derivatives
MXPA05009756A (es) Proceso para preparar ditioesteres.
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
CO5650237A2 (es) Procedimiento de sintesis selectiva de drivados de 2-amino-5-trifluorometil-pirimidina en presencia de un acido de lewis
JP2004532346A5 (de)
PL363990A1 (en) Arylsulfonamides as antiviral agents
Petrier et al. Ultrasonically improved reductive properties of an aqueous Zn NiCl2 system-2. Regioselectivity in the reduction of (−)-carvone
TW200604161A (en) Chemical process
KR950704256A (ko) 2―히드라지노피리딘 유도체를 사용하는 분자표시방법(molecule labelling using 2―hydrazinopyridine derivatives)
HUP0302467A2 (hu) Eljárás szulfonamidcsoporttal szubsztituált imidazotriazinon-származékok előállítására
DE60326465D1 (de) Herstellung von m(co)3-komplexen durch festphasentechniken durch metal-unterstützte trennung vom festen träger
WO2008117871A1 (ja) 含窒素レドックス触媒
KR850008348A (ko) N-치환 뉴라민산 유도체 및 그 제조방법
ATE454425T1 (de) Bitumenzusammensetzung
ECSP045222A (es) INHIBIDORES DE LA ADHESION CELULAR MEDIADA POR INTEGRINA aLb2
EP1693704A3 (de) Resistzusammensetzung und Verfahren zur Strukturformung damit
EP1215192A3 (de) Herstellungsverfahren von Dicarboxylsäureverbindungen
EA200300930A1 (ru) Способ получения n-замещенных 2,6-диалкилморфолинов
DE60237323D1 (de) Zusammensetzung enthaltend Ferrocen-Derivate und Treibstoff diese enthaltend
DE50311388D1 (de) Nicht-peptidische brs-3-agonisten
JP2010511042A5 (de)
TW200513464A (en) Method for producing organic compound by substituting halogen atoms
EP1083163A3 (de) Katalytisches Verfahren zur Herstellung von aromatischen Aminen unter Verwendung von Palladaphosphacyclobutanen
EP0900779A3 (de) Einstufiges Verfahren zur Herstellung von Aminen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition